Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Sujit G Bhansali & Vithal M Kulkarni. (2014) Pharmacophore generation, atom-based 3D-QSAR, docking, and virtual screening studies of p38-α mitogen activated protein kinase inhibitors: pyridopyridazin-6-ones (part 2). Research and Reports in Medicinal Chemistry 4, pages 1-21.
Read now
Read now
P. Singh & B. K. Sharma. (2007) Quantitative structure-activity relationship study of benzylsulfanyl imidazoles as cytokine release inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 22:1, pages 15-21.
Read now
Read now
Peter Norman. (2006) Allosteric p38 kinase inhibitors. Expert Opinion on Therapeutic Patents 16:10, pages 1443-1448.
Read now
Read now
Jeffrey Boehm. (2005) 5-Amino-2-carbonylthiophene derivatives for use as p38 MAPK inhibitors in the treatment of inflammatory diseases. Expert Opinion on Therapeutic Patents 15:10, pages 1471-1476.
Read now
Read now
Celia Dominguez, Nuria Tamayo & Dawei Zhang. (2005) p38 Inhibitors: beyond pyridinylimidazoles. Expert Opinion on Therapeutic Patents 15:7, pages 801-816.
Read now
Read now
. (2003) Novel 8-benzoylimidazo[1,2-a] pyridin-5-one mitogen-activated protein kinase inhibitors. Expert Opinion on Therapeutic Patents 13:10, pages 1663-1666.
Read now
Read now
. (2001) Amide derivatives useful for the treatment of diseases mediated by cytokines. Expert Opinion on Therapeutic Patents 11:9, pages 1471-1473.
Read now
Read now
Jacques Dumas. (2001) Protein kinase inhibitors: emerging pharmacophores 1997 - 2000. Expert Opinion on Therapeutic Patents 11:3, pages 405-429.
Read now
Read now
Peter Norman. (2001) Therapeutic approaches to respiratory diseases excluding asthma:Trends from the patent literature 1997 - 2000. Expert Opinion on Therapeutic Patents 11:2, pages 307-322.
Read now
Read now
. (2000) Amide derivatives as cytokine inhibitors. Expert Opinion on Therapeutic Patents 10:9, pages 1451-1454.
Read now
Read now
. (2000) A novel adenosine receptor pharmacophore. Expert Opinion on Therapeutic Patents 10:5, pages 729-732.
Read now
Read now
Articles from other publishers (60)
Ying Lv, Li Chen, Kun Li, Xing-Han Yun & Sheng-Jiao Yan. (2022)
Multicomponent Cascade Reaction of 3-Cyanochromones: Highly Site-Selective Synthesis of 2-(1
H
-Imidazol-1-yl)-4
H
-chromen-4-one Derivatives
. The Journal of Organic Chemistry 87:22, pages 15187-15196.
Crossref
Crossref
Sana Tariq, Ozair Alam & Mohammad Amir. (2018) Synthesis, p38α MAP kinase inhibition, anti-inflammatory activity, and molecular docking studies of 1,2,4-triazole-based benzothiazole-2-amines. Archiv der Pharmazie 351:3-4, pages 1700304.
Crossref
Crossref
Sana Tariq, Ozair Alam & Mohd. Amir. (2018) Synthesis, anti-inflammatory, p38α MAP kinase inhibitory activities and molecular docking studies of quinoxaline derivatives containing triazole moiety. Bioorganic Chemistry 76, pages 343-358.
Crossref
Crossref
Andrea Cappelli, Chiara Nannicini, Alessia Chelini, Marco Paolino, Germano Giuliani, Maurizio Anzini, Antonio Giordani, Chiara Sabatini, Gianfranco Caselli, Laura Mennuni, Francesco Makovec, Gianluca Giorgi, Salvatore Vomero & Maria Cristina Menziani. (2016) Phenylindenone isomers as divergent modulators of p38α MAP kinase. Bioorganic & Medicinal Chemistry Letters 26:21, pages 5160-5163.
Crossref
Crossref
Girish D. Hatnapure, Ashish P. Keche, Atish H. Rodge, Satish S. Birajdar, Rajesh H. Tale & Vandana M. Kamble. (2012) Synthesis and biological evaluation of novel piperazine derivatives of flavone as potent anti-inflammatory and antimicrobial agent. Bioorganic & Medicinal Chemistry Letters 22:20, pages 6385-6390.
Crossref
Crossref
Dijana Pešić, Ivana Ozimec Landek, Renata Rupčić, Marina Modrić, Iva Džapo []Rudolf Trojko []Mladen Merćep []Milan Mesić. (2012) Dibenzo[b,f]oxepin-10(11H)-one and dibenzo[b,f]thiepin-10(11H)-one as useful synthons in the synthesis of various dibenzo[e,h]azulenes. Journal of Heterocyclic Chemistry 49:2, pages 243-252.
Crossref
Crossref
Li Xing, Balekudru Devadas, Rajesh V. Devraj, Shaun R. Selness, Huey Shieh, John K. Walker, Michael Mao, Dean Messing, Brian Samas, Jerry Z. Yang, Gary D. Anderson, Elizabeth G. Webb & Joseph B. Monahan. (2012) Discovery and Characterization of Atropisomer PH-797804, a p38 MAP Kinase Inhibitor, as a Clinical Drug Candidate. ChemMedChem 7:2, pages 273-280.
Crossref
Crossref
Christine Dyrager, Linda Nilsson Möllers, Linda Karlsson Kjäll, John Patrick Alao, Peter Dinér, Fredrik K. Wallner, Per Sunnerhagen & Morten Grøtli. (2011) Design, Synthesis, and Biological Evaluation of Chromone-Based p38 MAP Kinase Inhibitors. Journal of Medicinal Chemistry 54:20, pages 7427-7431.
Crossref
Crossref
B. V. S. Suneel Kumar, Rohith Kotla, Revanth Buddiga, Jyoti Roy, Sardar Shamshair Singh, Rambabu Gundla, Muttineni Ravikumar & Jagarlapudi A. R. P. Sarma. (2010) Ligand-based and structure-based approaches in identifying ideal pharmacophore against c-Jun N-terminal kinase-3. Journal of Molecular Modeling 17:1, pages 151-163.
Crossref
Crossref
Arthur M. Doweyko. 2010. Drug Design. Drug Design
197
208
.
Renata Rupčić, Marina Modrić, Antun Hutinec, Ana Čikoš, Barbara Stanić, Milan Mesić, Dijana Pešić & Mladen Merćep. (2010) Novel tetracyclic imidazole derivatives: Synthesis, dynamic NMR study, and anti‐inflammatory evaluation. Journal of Heterocyclic Chemistry 47:3, pages 640-656.
Crossref
Crossref
Steve D. Fidanze, Scott A. Erickson, Gary T. Wang, Robert Mantei, Richard F. Clark, Bryan K. Sorensen, Nwe Y. Bamaung, Peter Kovar, Eric F. Johnson, Kerren K. Swinger, Kent D. Stewart, Qian Zhang, Lora A. Tucker, William N. Pappano, Julie L. Wilsbacher, Jieyi Wang, George S. Sheppard, Randy L. Bell, Steven K. Davidsen & Robert D. Hubbard. (2010) Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases. Bioorganic & Medicinal Chemistry Letters 20:8, pages 2452-2455.
Crossref
Crossref
Gregory R. Luedtke, Kurt Schinzel, Xuefei Tan, Richland W. Tester, Imad Nashashibi, Yong-jin Xu, Sundeep Dugar, Daniel E. Levy & Joon Jung. (2010) Amide-based inhibitors of p38α MAP kinase. Part 1: Discovery of novel N-pyridyl amide lead molecules. Bioorganic & Medicinal Chemistry Letters 20:8, pages 2556-2559.
Crossref
Crossref
Li Xing, Huey S. Shieh, Shaun R. Selness, Rajesh V. Devraj, John K. Walker, Balekudru Devadas, Heidi R. Hope, Robert P. Compton, John F. Schindler, Jeffrey L. Hirsch, Alan G. Benson, Ravi G. Kurumbail, Roderick A. Stegeman, Jennifer M. Williams, Richard M. Broadus, Zara Walden & Joseph B. Monahan. (2009) Structural Bioinformatics-Based Prediction of Exceptional Selectivity of p38 MAP Kinase Inhibitor PH-797804. Biochemistry 48:27, pages 6402-6411.
Crossref
Crossref
Ivana Ozimec Landek, Dijana Pešić, Predrag Novak, Barbara Stanić, Krunoslav Nujić, Mladen Merćep & Milan Mesić. (2009) 2,8-Dithia-dibenzo[e,h]azulenes and Their 8-Oxa Analogs. Synthesis and Anti-inflammatory Activity. HETEROCYCLES 78:10, pages 2489.
Crossref
Crossref
Chunjian Liu, James Lin, Sidney Pitt, Rosemary F. Zhang, John S. Sack, Susan E. Kiefer, Kevin Kish, Arthur M. Doweyko, Hongjian Zhang, Punit H. Marathe, James Trzaskos, Murray Mckinnon, John H. Dodd, Joel C. Barrish, Gary L. Schieven & Katerina Leftheris. (2008) Benzothiazole based inhibitors of p38α MAP kinase. Bioorganic & Medicinal Chemistry Letters 18:6, pages 1874-1879.
Crossref
Crossref
Dijana Pešić, Ivana Ozimec Landek, Ana Čikoš, Biserka Metelko, Vesna Gabelica, Barbara Stanić, Mladen Merćep & Milan Mesić. (2009)
Synthesis of 2‐formyl‐1‐aza‐dibenzo[
e
,
h
]azulenes
. Journal of Heterocyclic Chemistry 44:5, pages 1129-1133.
Crossref
Crossref
Robert SolivaJosep Lluis GelpíCarmen AlmansaMarina VirgiliModesto Orozco. (2006) Dissection of the Recognition Properties of p38 MAP Kinase. Determination of the Binding Mode of a New Pyridinyl−Heterocycle Inhibitor Family. Journal of Medicinal Chemistry 50:2, pages 283-293.
Crossref
Crossref
M.J. Elices & T. Arrhenius. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
969
985
.
Yuelie Lu, Tingjian Xiang, Michael D. Bartberger, Charles Bernard, Tracy Bostick, Liang Huang, Longbin Liu, Aaron Siegmund, Gregory Sukay, Gary Guo, Maria Silva Elipe, Wanda Tormos, Celia Dominguez, Kevin Koch, Laurence E. Burgess, Thomas C. Basil, Prabha Ibrahim & Conrad Hummel. (2006) An efficient one-pot construction of substituted pyrimidinones. Tetrahedron 62:50, pages 11714-11723.
Crossref
Crossref
Swaminathan R. Natarajan, Stephen T. Heller, Kiyean Nam, Suresh B. Singh, Giovanna Scapin, Sangita Patel, James E. Thompson, Catherine E. Fitzgerald & Stephen J. O’Keefe. (2006) p38 MAP kinase inhibitors. Part 6: 2-Arylpyridazin-3-ones as templates for inhibitor design. Bioorganic & Medicinal Chemistry Letters 16:22, pages 5809-5813.
Crossref
Crossref
Abdul Rajjak Shaikh, Mohamed Ismael, Carlos A. Del Carpio, Hideyuki Tsuboi, Michihisa Koyama, Akira Endou, Momoji Kubo, Ewa Broclawik & Akira Miyamoto. (2006) Three-dimensional quantitative structure–activity relationship (3 D-QSAR) and docking studies on (benzothiazole-2-yl) acetonitrile derivatives as c-Jun N-terminal kinase-3 (JNK3) inhibitors. Bioorganic & Medicinal Chemistry Letters 16:22, pages 5917-5925.
Crossref
Crossref
Mark Sabat, John C. VanRens, Michael P. Clark, Todd A. Brugel, Jennifer Maier, Roger G. Bookland, Matthew J. Laufersweiler, Steven K. Laughlin, Adam Golebiowski, Biswanath De, Lily C. Hsieh, Richard L. Walter, Marlene J. Mekel & Michael J. Janusz. (2006) The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-α production. Bioorganic & Medicinal Chemistry Letters 16:16, pages 4360-4365.
Crossref
Crossref
Pooja Sharma & Nanda Ghoshal. (2006) Exploration of a Binding Mode of Benzothiazol-2-yl Acetonitrile Pyrimidine Core Based Derivatives as Potent c-Jun N-Terminal Kinase-3 Inhibitors and 3D-QSAR Analyses. Journal of Chemical Information and Modeling 46:4, pages 1763-1774.
Crossref
Crossref
Todd A. Brugel, Jennifer A. Maier, Michael P. Clark, Mark Sabat, Adam Golebiowski, Roger G. Bookland, Matthew J. Laufersweiler, Steven K. Laughlin, John C. VanRens, Biswanath De, Lily C. Hsieh, Marlene J. Mekel & Michael J. Janusz. (2006) Development of N-2,4-pyrimidine-N-phenyl-N′-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 1. Bioorganic & Medicinal Chemistry Letters 16:13, pages 3510-3513.
Crossref
Crossref
Gerd Wagner & Stefan Laufer. (2006) Small molecular anti-cytokine agents. Medicinal Research Reviews 26:1, pages 1-62.
Crossref
Crossref
Adam Golebiowski, Jennifer A. Townes, Matthew J. Laufersweiler, Todd A. Brugel, Michael P. Clark, Cynthia M. Clark, Jane F. Djung, Steven K. Laughlin, Mark P. Sabat, Roger G. Bookland, John C. VanRens, Biswanath De, Lily C. Hsieh, Michael J. Janusz, Richard L. Walter, Mark E. Webster & Marlene J. Mekel. (2005) The development of monocyclic pyrazolone based cytokine synthesis inhibitors. Bioorganic & Medicinal Chemistry Letters 15:9, pages 2285-2289.
Crossref
Crossref
Nuria Tamayo, Lillian Liao, Martin Goldberg, David Powers, Yan-Yan Tudor, Violeta Yu, Lu Min Wong, Bradley Henkle, Scot Middleton, Rashid Syed, Timothy Harvey, Graham Jang, Randall Hungate & Celia Dominguez. (2005) Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters 15:9, pages 2409-2413.
Crossref
Crossref
Alfonso de Dios, Chuan Shih, Beatriz López de Uralde, Concepción Sánchez, Miriam del Prado, Luisa M. Martín Cabrejas, Sehila Pleite, Jaime Blanco-Urgoiti, María José Lorite, C. Richard Nevill, Rosanne Bonjouklian, Jeremy York, Michal Vieth, Yong Wang, Nicholas Magnus, Robert M. Campbell, Bryan D. Anderson, Denis J. McCann, Deborah D. Giera, Paul A. Lee, Richard M. Schultz, Li, Lea M. Johnson & Jeffrey A. Wolos. (2005) Design of Potent and Selective 2-Aminobenzimidazole-Based p38α MAP Kinase Inhibitors with Excellent in Vivo Efficacy. Journal of Medicinal Chemistry 48:7, pages 2270-2273.
Crossref
Crossref
Stefan A. Laufer, David M. Domeyer, Thomas R. F. Scior, Wolfgang Albrecht & Dominik R. J. Hauser. (2005) Synthesis and Biological Testing of Purine Derivatives as Potential ATP-Competitive Kinase Inhibitors. Journal of Medicinal Chemistry 48:3, pages 710-722.
Crossref
Crossref
Stefan A. Laufer, Werner Zimmermann & Kathrin J. Ruff. (2004) Tetrasubstituted Imidazole Inhibitors of Cytokine Release: Probing Substituents in the N-1 Position. Journal of Medicinal Chemistry 47:25, pages 6311-6325.
Crossref
Crossref
John G. Cumming, Caroline L. McKenzie, Stuart G. Bowden, Douglas Campbell, David J. Masters, Jason Breed & Philip J. Jewsbury. (2004) Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters 14:21, pages 5389-5394.
Crossref
Crossref
Donnie E. Shifflett, Samuel L. Jones, Adam J. Moeser & Anthony T. Blikslager. (2004) Mitogen-activated protein kinases regulate COX-2 and mucosal recovery in ischemic-injured porcine ileum. American Journal of Physiology-Gastrointestinal and Liver Physiology 286:6, pages G906-G913.
Crossref
Crossref
Gilberto M. Sperandio da Silva, Carlos M.R. Sant'Anna & Eliezer J. Barreiro. (2004) A novel 3D-QSAR comparative molecular field analysis (CoMFA) model of imidazole and quinazolinone functionalized p38 MAP kinase inhibitors. Bioorganic & Medicinal Chemistry 12:12, pages 3159-3166.
Crossref
Crossref
Erik Rytter Ottosen, Morten Dahl Sørensen, Fredrik Björkling, Tine Skak-Nielsen, Marianne Scheel Fjording, Helle Aaes & Lise Binderup. (2003) Synthesis and Structure−Activity Relationship of Aminobenzophenones. A Novel Class of p38 MAP Kinase Inhibitors with High Antiinflammatory Activity. Journal of Medicinal Chemistry 46:26, pages 5651-5662.
Crossref
Crossref
Alejandra Trejo, Humberto Arzeno, Michelle Browner, Sushmita Chanda, Soan Cheng, Daniel D. Comer, Stacie A. Dalrymple, Pete Dunten, JoAnn Lafargue, Brett Lovejoy, Jose Freire-Moar, Julie Lim, Joel Mcintosh, Jennifer Miller, Eva Papp, Deborah Reuter, Rick Roberts, Florentino Sanpablo, John Saunders, Kyung Song, Armando Villasenor, Stephen D. Warren, Mary Welch, Paul Weller, Phyllis E. Whiteley, Lu Zeng & David M. Goldstein. (2003) Design and Synthesis of 4-Azaindoles as Inhibitors of p38 MAP Kinase. Journal of Medicinal Chemistry 46:22, pages 4702-4713.
Crossref
Crossref
Catherine E Fitzgerald, Sangita B Patel, Joseph W Becker, Patricia M Cameron, Dennis Zaller, Vasilis Bill Pikounis, Stephen J O'Keefe & Giovanna Scapin. (2003) Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity. Nature Structural & Molecular Biology 10:9, pages 764-769.
Crossref
Crossref
Sanjay Kumar, Jeffrey Boehm & John C. Lee. (2003) p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nature Reviews Drug Discovery 2:9, pages 717-726.
Crossref
Crossref
Giovanna Scapin, Sangita B. Patel, JeanMarie Lisnock, Joseph W. Becker & Philip V. LoGrasso. (2003) The Structure of JNK3 in Complex with Small Molecule Inhibitors. Chemistry & Biology 10:8, pages 705-712.
Crossref
Crossref
Stefan A. Laufer, Gerd K. Wagner, Dunja A. Kotschenreuther & W. Albrecht. (2003) Novel Substituted Pyridinyl Imidazoles as Potent Anticytokine Agents with Low Activity against Hepatic Cytochrome P450 Enzymes. Journal of Medicinal Chemistry 46:15, pages 3230-3244.
Crossref
Crossref
Zehong Wan, Jeffrey C. Boehm, Michael J. Bower, Shouki Kassis, John C. Lee, Baoguang Zhao & Jerry L. Adams. (2003) N-Phenyl-N-purin-6-yl ureas: The design and synthesis of p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 13:6, pages 1191-1194.
Crossref
Crossref
Steven L. Colletti, Jessica L. Frie, Elizabeth C. Dixon, Suresh B. Singh, Bernard K. Choi, Giovanna Scapin, Catherine E. Fitzgerald, Sanjeev Kumar, Elizabeth A. Nichols, Stephen J. O'Keefe, Edward A. O'Neill, Gene Porter, Koppara Samuel, Dennis M. Schmatz, Cheryl D. Schwartz, Wesley L. Shoop, Chris M. Thompson, James E. Thompson, Ruixiu Wang, Andrea Woods, Dennis M. Zaller & James B. Doherty. (2002)
Hybrid-Designed Inhibitors of p38 MAP Kinase Utilizing
N
-Arylpyridazinones
. Journal of Medicinal Chemistry 46:3, pages 349-352.
Crossref
Crossref
Swaminathan R. Natarajan, David D. Wisnoski, Suresh B. Singh, John E. Stelmach, Edward A. O'Neill, Cheryl D. Schwartz, Chris M. Thompson, Catherine E. Fitzgerald, Stephen J. O'Keefe, Sanjeev Kumar, Cornelis E.C.A. Hop, Dennis M. Zaller, Dennis M. Schmatz & James B. Doherty. (2003) p38MAP kinase inhibitors. part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffold. Bioorganic & Medicinal Chemistry Letters 13:2, pages 273-276.
Crossref
Crossref
John E. Stelmach, Luping Liu, Sangita B. Patel, James V. Pivnichny, Giovanna Scapin, Suresh Singh, Cornelis E.C.A. Hop, Zhen Wang, John R. Strauss, Patricia M. Cameron, Elizabeth A. Nichols, Stephen J. O'Keefe, Edward A. O'Neill, Dennis M. Schmatz, Cheryl D. Schwartz, Chris M. Thompson, Dennis M. Zaller & James B. Doherty. (2003) Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters 13:2, pages 277-280.
Crossref
Crossref
Stefan A. Laufer, Hans-Günther Striegel & Gerd K. Wagner. (2002) Imidazole Inhibitors of Cytokine Release: Probing Substituents in the 2 Position. Journal of Medicinal Chemistry 45:21, pages 4695-4705.
Crossref
Crossref
John Regan, Steffen Breitfelder, Pier Cirillo, Thomas Gilmore, Anne G. Graham, Eugene Hickey, Bernhard Klaus, Jeffrey Madwed, Monica Moriak, Neil Moss, Chris Pargellis, Sue Pav, Alfred Proto, Alan Swinamer, Liang Tong & Carol Torcellini. (2002) Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate. Journal of Medicinal Chemistry 45:14, pages 2994-3008.
Crossref
Crossref
Elaine A. IrvingMark Bamford. (2016) Role of Mitogen- and Stress-Activated Kinases in Ischemic Injury. Journal of Cerebral Blood Flow & Metabolism 22:6, pages 631-647.
Crossref
Crossref
Stefan A. Laufer & Gerd K. Wagner. (2002) From Imidazoles to Pyrimidines: New Inhibitors of Cytokine Release. Journal of Medicinal Chemistry 45:13, pages 2733-2740.
Crossref
Crossref
Jeffrey M. McKenna, Frank Halley, John E. Souness, Iain M. McLay, Stephen D. Pickett, Alan J. Collis, Kenneth Page & Imtiaz Ahmed. (2002) An Algorithm-Directed Two-Component Library Synthesized Via Solid-Phase Methodology Yielding Potent and Orally Bioavailable p38 MAP Kinase Inhibitors. Journal of Medicinal Chemistry 45:11, pages 2173-2184.
Crossref
Crossref
James F. Callahan, Joelle L. Burgess, James A. Fornwald, Laramie M. Gaster, John D. Harling, Frank P. Harrington, Jag Heer, Chet Kwon, Ruth Lehr, A. Mathur, Barbara A. Olson, Joseph Weinstock & Nicholas J. Laping. (2002) Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5). Journal of Medicinal Chemistry 45:5, pages 999-1001.
Crossref
Crossref
Charles J McIntyre, Gerald S Ponticello, Nigel J Liverton, Stephen J O’Keefe, Edward A O’Neill, Margaret Pang, Cheryl D Schwartz & David A Claremon. (2002) Pyridazine based inhibitors of p38 MAPK. Bioorganic & Medicinal Chemistry Letters 12:4, pages 689-692.
Crossref
Crossref
Alexandros A. Drosos. (2002) Newer Immunosuppressive Drugs. Drugs 62:6, pages 891-907.
Crossref
Crossref
Jessie M. English & Melanie H. Cobb. (2002) Pharmacological inhibitors of MAPK pathways. Trends in Pharmacological Sciences 23:1, pages 40-45.
Crossref
Crossref
Alexander J. Bridges. (2001) Chemical Inhibitors of Protein Kinases. Chemical Reviews 101:8, pages 2541-2572.
Crossref
Crossref
Iain M. McLay, Frank Halley, John E. Souness, Jeffrey McKenna, Veronique Benning, Mark Birrell, Brenda Burton, Maria Belvisi, Alan Collis, Alex Constan, Martyn Foster, David Hele, Zaid Jayyosi, Mike Kelley, Chris Maslen, Glen Miller, Marie-Claude Ouldelhkim, Kenneth Page, Simon Phipps, Kenneth Pollock, Barry Porter, Andrew J. Ratcliffe, Elisabeth J. Redford, Stephen Webber, Bryan Slater, Veronique Thybaud & Nicola Wilsher. (2001) The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy. Bioorganic & Medicinal Chemistry 9:2, pages 537-554.
Crossref
Crossref
Jerry L. Adams, Alison M. Badger, Sanjay Kumar & John C. Lee. 2001.
1
60
.
Bernard PirardStephen D. Pickett. (2000) Classification of Kinase Inhibitors Using BCUT Descriptors. Journal of Chemical Information and Computer Sciences 40:6, pages 1431-1440.
Crossref
Crossref
Jacques Dumas, Robert Sibley, Bernd Riedl, Mary Katherine Monahan, Wendy Lee, Timothy B Lowinger, Anikó M Redman, Jeffrey S Johnson, Jill Kingery-Wood, William J Scott, Roger A Smith, Mark Bobko, Robert Schoenleber, Gerald E Ranges, Timothy J Housley, Ajay Bhargava, Scott M Wilhelm & Alka Shrikhande. (2000) Discovery of a new class of p38 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 10:18, pages 2047-2050.
Crossref
Crossref
John C Lee, Sanjay Kumar, Don E Griswold, David C Underwood, Bartholomew J Votta & Jerry L Adams. (2000) Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 47:2-3, pages 185-201.
Crossref
Crossref
Mark Bamford, Gail Walkinshaw & Robin Brown. (2000) Therapeutic Applications of Apoptosis Research. Experimental Cell Research 256:1, pages 1-11.
Crossref
Crossref